Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)

Delayed Data
As of Jul 01
 +0.0059 / +1.17%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Aeglea Bio Therapeutics Inc have a median target of 3.00, with a high estimate of 8.00 and a low estimate of 1.00. The median estimate represents a +487.08% increase from the last price of 0.51.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Aeglea Bio Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 15.24%
Growthannually -28.54%


Growthquarterly -58.33%
Growthannually -85.43%
Key to the earnings and sales forecast charts.